
Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing
Description
Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032
Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW
Biopharmaceutical Market size was USD 311.2 billion in 2021 and projected to grow from USD 376.2 billion in 2023 to USD 895.2 billion by 2032, exhibiting a CAGR of 10.1% during the forecast period.
Biopharmaceuticals are also referred as biologics or biologic drugs which are medical products obtained from biological sources like living organisms, proteins etc. Biopharmaceuticals are the drugs originated using biotechnology procedures and are important in modern healthcare. Biopharmaceuticals are also designed to target specific molecular characteristics of disease related to patients which is a customized treatment.
MARKET HIGHLIGHTS
Biopharmaceutical Market is expected to reach USD 895.2 billion, growing at a CAGR of 10.1% during forecast period owing to the increasing prevalence of chronic diseases and rising geriatric population which may boost the demand for growth of biopharmaceutical market. Biopharmaceuticals provide targeted therapies and have less side effects along with enhanced efficiency. The increasing research and development activities along with the usage growing usage of monoclonal antibodies in therapeutics of in vitro diagnostics is bolstering the growth of the Biopharmaceutical market.
Biopharmaceutical Market Segments:
- Product Type
- Purified Proteins
- Recombinant Growth Factors
- Recombinant Proteins
- Recombinant Hormone
- Synthetic Immunomodulatory
- Monoclonal Antibodies
- Vaccines
- Other
- Service
- Custom Testing / Customer Proprietary Testing
- Laboratory Testing
- Compendial, and Multi Compendial Laboratory Testing
- Raw Material Type
- Active Pharmaceutical Ingredients (API)
- Formulation Excipients
- Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support
- Application
- Autoimmune Disorders
- Metabolic Disorders
- Oncology
- Inflammatory and Infectious Diseases
- Hormonal Disorders
- Neurological Diseases
- Cardiovascular Diseases
- Other
Growth Drivers
Increasing Necessity of Biopharmaceuticals are Expected to Boost the Growth of the Market
Rising Investment in Healthcare is Expected to Boost the Growth of the Market
Restraint
Safety Issues May Restrain the Growth of the Market
Key Players
- Amgen Inc.
- AstraZeneca
- Johnson & Johnson Private Limited
- Lilly
- Pfizer Inc.
- Sanofi
- Abbott
- Novartis AG
- F. Hoffmann-La Roche Ltd.
- Novo Nordisk A/S
- bioMérieux
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Bayer AG
- Biogen
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
390 Pages
- 1. Executive Summary
- 1.1.Regional Market Share
- 1.2. Business Trends
- 1.3. Biopharmaceutical Market: COVID-19 Outbreak
- 1.4.Regional Trends
- 1.5. Segmentation Snapshot
- 2. Research Methodology
- 2.1. Research Objective
- 2.2.Research Approach
- 2.3.Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1.Paid Sources
- 2.5.2. Public Sources
- 2.6.Market Size Estimation and Data Triangulation
- 3. Market Characteristics
- 3.1. Market Definition
- 3.2.Biopharmaceutical Market: COVID-19 Impact
- 3.3.Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4. Biopharmaceutical Market – Industry Insights
- 4.1.Industry Segmentation
- 4.2. COVID-19 overview on world economy
- 4.3. Industry ecosystem Channel analysis
- 4.4. Innovation & Sustainability
- 5. Macroeconomic Indicators
- 6. Recent Developments
- 7.Market Dynamics
- 7.1. Introduction
- 7.2.Growth Drivers
- 7.3.Market Opportunities
- 7.4. Market Restraints
- 7.5.Market Trends
- 8. Risk Analysis
- 9. Market Analysis
- 9.1. Porters Five Forces
- 9.2.PEST Analysis
- 9.2.1. Political
- 9.2.2.Economic
- 9.2.3.Social
- 9.2.4.Technological
- 10. Biopharmaceutical Market
- 10.1.Overview
- 10.2. Historical Analysis (2016-2021)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11.Biopharmaceutical Market Size & Forecast 2022A-2032F
- 11.1.Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1.By Product Type
- 11.3.1.1. Purified Proteins
- 11.3.1.1.1. By Value (USD Million) 2022-2032F
- 11.3.1.1.2.Market Share (%) 2022-2032F
- 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.1.2.Recombinant Growth Factors
- 11.3.1.2.1.By Value (USD Million) 2022-2032F
- 11.3.1.2.2. Market Share (%) 2022-2032F
- 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.3.Recombinant Proteins
- 11.3.1.3.1.By Value (USD Million) 2022-2032F
- 11.3.1.3.2. Market Share (%) 2022-2032F
- 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.4.Recombinant Hormone
- 11.3.1.4.1.By Value (USD Million) 2022-2032F
- 11.3.1.4.2. Market Share (%) 2022-2032F
- 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.5.Synthetic Immunomodulatory
- 11.3.1.5.1.By Value (USD Million) 2022-2032F
- 11.3.1.5.2. Market Share (%) 2022-2032F
- 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.6.Monoclonal Antibodies
- 11.3.1.6.1.By Value (USD Million) 2022-2032F
- 11.3.1.6.2. Market Share (%) 2022-2032F
- 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.7.Vaccines
- 11.3.1.7.1.By Value (USD Million) 2022-2032F
- 11.3.1.7.2. Market Share (%) 2022-2032F
- 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.8.Other
- 11.3.1.8.1.By Value (USD Million) 2022-2032F
- 11.3.1.8.2. Market Share (%) 2022-2032F
- 11.3.1.8.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2. By Service
- 11.3.2.1.Custom Testing / Customer Proprietary Testing
- 11.3.2.1.1.By Value (USD Million) 2022-2032F
- 11.3.2.1.2. Market Share (%) 2022-2032F
- 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.2. Laboratory Testing
- 11.3.2.2.1. By Value (USD Million) 2022-2032F
- 11.3.2.2.2.Market Share (%) 2022-2032F
- 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.2.3. Compendial, and Multi Compendial Laboratory Testing
- 11.3.2.3.1. By Value (USD Million) 2022-2032F
- 11.3.2.3.2.Market Share (%) 2022-2032F
- 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.3. By Raw Material Type
- 11.3.3.1.Active Pharmaceutical Ingredients (API)
- 11.3.3.1.1.By Value (USD Million) 2022-2032F
- 11.3.3.1.2. Market Share (%) 2022-2032F
- 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.2. Formulation Excipients
- 11.3.3.2.1. By Value (USD Million) 2022-2032F
- 11.3.3.2.2.Market Share (%) 2022-2032F
- 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.3.3. Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support
- 11.3.3.3.1. By Value (USD Million) 2022-2032F
- 11.3.3.3.2.Market Share (%) 2022-2032F
- 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.4. By Application
- 11.3.4.1.Autoimmune Disorders
- 11.3.4.1.1.By Value (USD Million) 2022-2032F
- 11.3.4.1.2. Market Share (%) 2022-2032F
- 11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.2. Metabolic Disorders
- 11.3.4.2.1. By Value (USD Million) 2022-2032F
- 11.3.4.2.2.Market Share (%) 2022-2032F
- 11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.3. Oncology
- 11.3.4.3.1. By Value (USD Million) 2022-2032F
- 11.3.4.3.2. Market Share (%) 2022-2032F
- 11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.4. Inflammatory and Infectious Diseases
- 11.3.4.4.1.By Value (USD Million) 2022-2032F
- 11.3.4.4.2. Market Share (%) 2022-2032F
- 11.3.4.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.5. Hormonal Disorders
- 11.3.4.5.1.By Value (USD Million) 2022-2032F
- 11.3.4.5.2. Market Share (%) 2022-2032F
- 11.3.4.5.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.6. Neurological Diseases
- 11.3.4.6.1. By Value (USD Million) 2022-2032F
- 11.3.4.6.2.Market Share (%) 2022-2032F
- 11.3.4.6.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.4.7. Cardiovascular Diseases
- 11.3.4.7.1. By Value (USD Million) 2022-2032F
- 11.3.4.7.2.Market Share (%) 2022-2032F
- 11.3.4.7.3.Y-o-Y Growth (%) 2022-2032F
- 11.3.4.8. Other
- 11.3.4.8.1.By Value (USD Million) 2022-2032F
- 11.3.4.8.2. Market Share (%) 2022-2032F
- 11.3.4.8.3. Y-o-Y Growth (%) 2022-2032F
- 12. North America Biopharmaceutical Market Size & Forecast 2022A-2032F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Product Type
- 12.3.2.By Service
- 12.3.3.By Raw Material Type
- 12.3.4.By Application
- 12.4. Country
- 12.4.1.United States
- 12.4.2. Canada
- 13. Europe Biopharmaceutical Market Size & Forecast 2022A-2032F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Product Type
- 13.3.2.By Service
- 13.3.3.By Raw Material Type
- 13.3.4.By Application
- 13.4. Country
- 13.4.1.Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14. Asia Biopharmaceutical Market Size & Forecast 2022A-2032F
- 14.1.Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Product Type
- 14.3.2.By Service
- 14.3.3.By Raw Material Type
- 14.3.4. By Application
- 14.4. Country
- 14.4.1.India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15. Middle East and Africa Biopharmaceutical Market Size & Forecast 2022A-2032F
- 15.1.Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Product Type
- 15.3.2.By Service
- 15.3.3.By Raw Material Type
- 15.3.4.By Application
- 15.4. Country
- 15.4.1.Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16. Latin America Biopharmaceutical Market Size & Forecast 2022A-2032F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Product Type
- 16.3.2.By Service
- 16.3.3.By Raw Material Type
- 16.3.4.By Application
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17. Competitive Landscape
- 17.1. Company market share, 2021
- 17.2.Key player overview
- 17.3. Key stakeholders
- 18. Company Profiles
- 18.1.Amgen Inc.
- 18.1.1.Company Overview
- 18.1.2.Financial Overview
- 18.1.3.Key Product; Analysis
- 18.1.4.Company Assessment
- 18.1.4.1.Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. AstraZeneca
- 18.3. Johnson & Johnson Private Limited
- 18.4.Lilly
- 18.5. Pfizer Inc.
- 18.6. Sanofi
- 18.7. Abbott
- 18.8.Novartis AG
- 18.9. F. Hoffmann-La Roche Ltd.
- 18.10.Novo Nordisk A/S
- 18.11.bioMérieux
- 18.12.Merck & Co., Inc.
- 18.13.Bristol-Myers Squibb Company
- 18.14.GlaxoSmithKline Plc
- 18.15.Bayer AG
- 18.16. Biogen
- 18.17. Other Prominent Players
- 19. Appendix
- 20.Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.